Who Paid My Doc
Er-Reboa Plus
Device Dqy
General payments
$705,279
Research payments
$29,953
Through program year 2025, $705,279 in general payments and $29,953 in research payments were reported against Er-Reboa Plus (Dqy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,708 | 103 |
| 2024 | General | $64,178 | 229 |
| 2023 | General | $253,526 | 363 |
| 2022 | General | $202,819 | 79 |
| 2021 | General | $173,048 | 46 |
| 2021 | Research | $29,953 | 1 |
Breakdown
The top 5 of 88 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
820 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.